Michael B. Atkins, MD, regarding the long-term follow up of Checkmate-004 in metastatic melanoma

Michael B. Atkins, MD, regarding the long-term follow up of Checkmate-004 in metastatic melanoma

Publication date: Jun 10, 2019

Dr. Atkins, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical Center, tells us about outcomes from the long-term follow up of Checkmate-004 in metastatic melanoma

Concepts Keywords
Checkmate Combination melanoma
Concurrent Melanoma
England Medicine
FDA Clinical medicine
Georgetown Melanoma
Graft Cancer treatments
Ldh RTT
LDH Antineoplastic drugs
Melanoma Uveal melanoma
Mutant Ipilimumab
Mutation
Nivea
Oncology
Stratification
Toxicity

Semantics

Type Source Name
disease DOID Cancer
disease MESH Cancer
pathway BSID Melanoma
disease DOID melanoma
disease MESH melanoma

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *